Results 61 to 70 of about 5,508 (182)

Comparison of the Effectiveness and Tolerability of Nabiximols (THC:CBD) Oromucosal Spray versus Oral Dronabinol (THC) as Add-on Treatment for Severe Neuropathic Pain in Real-World Clinical Practice: Retrospective Analysis of the German Pain e-Registry

Journal of Pain Research, 2022
Michael A Ueberall,1 Ute Essner,2 Carlos Vila Silván,3 Gerhard HH Mueller-Schwefe4 1Center of Excellence in Health Care Research of the German Pain Association, Institute of Neurological Sciences, Nuernberg, Germany; 2Medical Department, O.
Ueberall MA, Essner U, Vila Silván C, Mueller-Schwefe GHH   +3 more
doaj  

Personality Traits and Their Association With Medication Non‐Adherence in Patients With Multiple Sclerosis

CNS Neuroscience &Therapeutics, Volume 32, Issue 7, July 2026.
This cross‐sectional study investigated the role of personality traits in medication non‐adherence among patients with multiple sclerosis. Non‐adherence, reported by 19.9% of the patients, was linked to younger age, lower disease severity, and distinct psychological profiles, including lower self‐directedness, higher shyness, and higher anxiety scores.
Pegah Mashhadiakbar, Michael Hecker, Niklas Frahm, Julia Baldt, Bassel Barhoum, Katja Burian, Silvan Elias Langhorst, Janina Meißner, Barbara Streckenbach, Avinash Mohnish Suntah, Jörg Richter, Felicita Heidler, Uwe Klaus Zettl   +12 more
wiley   +1 more source

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial. [PDF]

, 2013
Laboratory evidence has shown that cannabinoids might have a neuroprotective action. We investigated whether oral dronabinol (Δ(9)-tetrahydrocannabinol) might slow the course of progressive multiple ...
Hobart, Jeremy, Vickery, J, CUPID investigator group, Wright, D, Vickery, Jane, Ball, S, Mallik, S, Miller, D, Gomez Cano, Mayam, Zajicek, J, Hobart, J, Nunn, A, Miller, David, Wright, David, Mallik, Sharukh, McManus, D, ?, ?, McManus, David, Gomez Cano, M, Ball, Susan, Zajicek, John, Nunn, Andrew   +21 more
core   +1 more source

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

International Journal of Eating Disorders, Volume 59, Issue 7, Page 1576-1587, July 2026.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota, David J. Grelotti, Tyler Nguyen, Walter H. Kaye, Skylar Swindle, Raymond Suhandynata, Spencer Seely, Megan E. Shott, Guido K. W. Frank   +8 more
wiley   +1 more source

Management Approach for Anorexia in Palliative Care: An Integrative Literature Review / Condutas para o Manejo da Anorexia em Cuidados Paliativos: Revisão Integrativa

Revista de Pesquisa Cuidado é Fundamental Online, 2020
Objetivo: Identificar as evidências científicas acerca das condutas para o manejo da anorexia em cuidados paliativos. Métodos: Trata-se de uma revisão integrativa, cujo levantamento bibliográfico dos dados deu-se através da pesquisa em quatro bases de ...
Raquel Bezerra Barbosa de Moura, Ângelo Brito Pereira de Melo, Thamires Ribeiro Chaves, Luciana Maria Martinez Vaz, Janine Maciel Barbosa, Renan Gondim Araújo   +5 more
doaj   +1 more source

International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction There have been concerted research efforts internationally to examine the health effects of higher delta‐9‐tetrahydrocannabinol (THC) concentration cannabis products and to design policies to reduce potential negative health effects of their use.
Myfanwy Graham, Dereje Assefa, Adrian Carter, Suzanne Nielsen   +3 more
wiley   +1 more source

Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients

, 2017
Treatment of neuropathic pain (NP) symptoms associated with multiple sclerosis (MS) is frequently insufficient. Yet, cannabis is still rarely offered for treatment of pain.
Martin Marziniak, Eva Maria Kugler, Dimitri Abramov-Sommariva, Gudrun Werner, Christine Neubauer, Sebastian Schimrigk   +5 more
core   +1 more source

A Feasibility Assessment of the FDA Adverse Event Reporting System for the Detection of Cannabis‐Related Safety Signals

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 6, June 2026.
ABSTRACT Background The applicability of spontaneous reporting systems such as the US Food and Drug Administration Adverse Event Reporting System (FAERS) to detect cannabis‐related safety signals remains unclear due to the potential for discrepant reporting patterns between pharmaceutical and non‐pharmaceutical cannabis‐derived products (CDPs ...
Priscilla O. M. V. Lopes, Cory S. Harris, Christopher A. Gravel   +2 more
wiley   +1 more source

Cannabinoides en porros de resina de cannabis decomisados en Castilla y León

Anales del Sistema Sanitario de Navarra
Fundamento. El cannabis, en sus productos hierba y resina, es la droga ilegal más consumida en el mundo. El objetivo del estudio es conocer la riqueza y disponibilidad de los principales cannabinoides en la resina de cannabis en los porros circulantes a ...
Eduardo Tejedor-Tejada, Jesús Miguel Tejedor Muñoz   +1 more
doaj   +1 more source

Cannabinoids and drug–drug pharmacokinetic interactions: Deciphering the risks

British Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1287-1308, May 2026.
The relationship between cannabinoids and mental health has become a major focus of scientific inquiry and public discourse. Cannabinoids are diverse chemical compounds from the Cannabis species that have been explored for their therapeutic applications in treating chronic pain, psychiatric and neurological conditions, such as depression, schizophrenia,
Paraskevi Papakyriakopoulou, Georgia Valsami, Georgios Ismailos   +2 more
wiley   +1 more source